XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,903 | -38.8% | 2,866 | -31.0% | 0.00% | – |
| Q2 2023 | $159,929 | -42.8% | 4,154 | -46.9% | 0.00% | – |
| Q1 2023 | $279,770 | +292.2% | 7,817 | +332.1% | 0.00% | – |
| Q4 2022 | $71,329 | +15.0% | 1,809 | +5.4% | 0.00% | – |
| Q3 2022 | $62,000 | +6.9% | 1,717 | -10.5% | 0.00% | – |
| Q2 2022 | $58,000 | -98.1% | 1,918 | -98.1% | 0.00% | -100.0% |
| Q1 2022 | $3,133,000 | +4251.4% | 102,475 | +4353.5% | 0.00% | – |
| Q4 2021 | $72,000 | +80.0% | 2,301 | -12.5% | 0.00% | – |
| Q3 2021 | $40,000 | -28.6% | 2,629 | -12.4% | 0.00% | – |
| Q2 2021 | $56,000 | +229.4% | 3,000 | +212.2% | 0.00% | – |
| Q1 2021 | $17,000 | -22.7% | 961 | -31.7% | 0.00% | – |
| Q4 2020 | $22,000 | +633.3% | 1,406 | +381.5% | 0.00% | – |
| Q3 2020 | $3,000 | -95.2% | 292 | -94.1% | 0.00% | – |
| Q2 2020 | $62,000 | +244.4% | 4,939 | +265.3% | 0.00% | – |
| Q4 2019 | $18,000 | +200.0% | 1,352 | +99.4% | 0.00% | – |
| Q3 2019 | $6,000 | -40.0% | 678 | -32.1% | 0.00% | – |
| Q2 2019 | $10,000 | +25.0% | 999 | +32.7% | 0.00% | – |
| Q1 2019 | $8,000 | +100.0% | 753 | +25.5% | 0.00% | – |
| Q4 2018 | $4,000 | -50.0% | 600 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | +33.3% | 600 | -14.3% | 0.00% | – |
| Q2 2018 | $6,000 | +100.0% | 700 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | +50.0% | 700 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 700 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -16.7% | 700 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | +50.0% | 700 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -20.0% | 700 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -16.7% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | +500.0% | 700 | +1272.5% | 0.00% | – |
| Q2 2015 | $1,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |